Reuters logo
BRIEF-Mabvax Therapeutics gets U.S. patent for its monoclonal antibody
November 7, 2016 / 2:13 PM / a year ago

BRIEF-Mabvax Therapeutics gets U.S. patent for its monoclonal antibody

Nov 7 (Reuters) - Mabvax Therapeutics Holdings Inc

* Mabvax Therapeutics receives U.S. Patent for its clinical stage humab-5b1 antibody Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below